Betapharma takes all possible measures towards metting the needs of client in terms of product quality and its services. It firmly believes its untiring effortd to fulfill its mission in good faith will bring satisfaction to its clients.
Our company is capable of providing the patent technology transfer. We have acquired 17 patents technology in USA and China. Icotinib, one of the patents technology, we have made over it to Zhejiang Beta Pharma Inc in 2003, They have exploited this New Drug successful, so far, Phase I completed in healthy volunteers and Chinese NSCLC patients, and Phase III trial in Chinese NSCLC patients is nearing completion. In a dose-dependent manner, Icotinib has a disease control rate of 56%-90% in Chinese NSCLC patients.
We specialize in a full spectrum of pharmaceutical research services such as:
We routinely carry out multi-step sequences to prepare gram to kilogram quantities. Typical procedures include
Company Name: | Betapharma(Shanghai)Co., Ltd. |
---|---|
Company Website URL: | http://www.betapharma.cn |
Factory Location: | No.17#-6D. 830 Lane, Maotai Road, Shanghai 200336, ,, China |
---|